208 related articles for article (PubMed ID: 27936167)
1. The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?
Seemanova E; Varon R; Vejvalka J; Jarolim P; Seeman P; Chrzanowska KH; Digweed M; Resnick I; Kremensky I; Saar K; Hoffmann K; Dutrannoy V; Karbasiyan M; Ghani M; Barić I; Tekin M; Kovacs P; Krawczak M; Reis A; Sperling K; Nothnagel M
PLoS One; 2016; 11(12):e0167984. PubMed ID: 27936167
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk of heterozygotes with the NBN founder mutation.
Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
[TBL] [Abstract][Full Text] [Related]
3. [Heterozygous carriers of Slavic mutation 657del5 of NBN gene in patients with colorectal cancer].
Seemanová E; Hoch J; Seeman P
Cas Lek Cesk; 2011; 150(2):97-9. PubMed ID: 21560448
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of the BRCT tandem domains of nibrin by the 657del5 mutation affects the DNA damage response less than the Arg215Trp mutation.
Mendez G; Cilli D; Berardinelli F; Viganotti M; Ascenzi P; Tanzarella C; Antoccia A; di Masi A
IUBMB Life; 2012 Oct; 64(10):853-61. PubMed ID: 22941933
[TBL] [Abstract][Full Text] [Related]
5. Nijmegen breakage syndrome (NBS) with neurological abnormalities and without chromosomal instability.
Seemanová E; Sperling K; Neitzel H; Varon R; Hadac J; Butova O; Schröck E; Seeman P; Digweed M
J Med Genet; 2006 Mar; 43(3):218-24. PubMed ID: 16033915
[TBL] [Abstract][Full Text] [Related]
6. The NBN founder mutation-Evidence for a country specific difference in age at cancer manifestation.
Chrzanowska KH; Seemanova E; Varon R; Digweed M; Piekutowska-Abramczuk D; Sperling K; Seeman P
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1700. PubMed ID: 36806726
[TBL] [Abstract][Full Text] [Related]
7. Identification of the interactors of human nibrin (NBN) and of its 26 kDa and 70 kDa fragments arising from the NBN 657del5 founder mutation.
Cilli D; Mirasole C; Pennisi R; Pallotta V; D'Alessandro A; Antoccia A; Zolla L; Ascenzi P; di Masi A
PLoS One; 2014; 9(12):e114651. PubMed ID: 25485873
[TBL] [Abstract][Full Text] [Related]
8. NBN 657del5 heterozygous mutations and colorectal cancer risk in the Czech Republic.
Pardini B; Naccarati A; Polakova V; Smerhovsky Z; Hlavata I; Soucek P; Novotny J; Vodickova L; Tomanova V; Landi S; Vodicka P
Mutat Res; 2009 Jun; 666(1-2):64-7. PubMed ID: 19393249
[TBL] [Abstract][Full Text] [Related]
9. Geographical Distribution, Incidence, Malignancies, and Outcome of 136 Eastern Slavic Patients With Nijmegen Breakage Syndrome and
Sharapova SO; Pashchenko OE; Bondarenko AV; Vakhlyarskaya SS; Prokofjeva T; Fedorova AS; Savchak I; Mareika Y; Valiev TT; Popa A; Tuzankina IA; Vlasova EV; Sakovich IS; Polyakova EA; Rumiantseva NV; Naumchik IV; Kulyova SA; Aleshkevich SN; Golovataya EI; Minakovskaya NV; Belevtsev MV; Latysheva EA; Latysheva TV; Beznoshchenko AG; Akopyan H; Makukh H; Kozlova O; Varabyou DS; Ballow M; Ong MS; Walter JE; Kondratenko IV; Kostyuchenko LV; Aleinikova OV
Front Immunol; 2020; 11():602482. PubMed ID: 33488600
[TBL] [Abstract][Full Text] [Related]
10. Clinical variability and expression of the NBN c.657del5 allele in Nijmegen Breakage Syndrome.
Lins S; Kim R; Krüger L; Chrzanowska KH; Seemanova E; Digweed M
Gene; 2009 Nov; 447(1):12-7. PubMed ID: 19635536
[TBL] [Abstract][Full Text] [Related]
11. Regional distribution of heterozygous 657del5 mutation carriers of the NBS1 gene in Wielkopolska province (Poland).
Ziółkowska I; Mosor M; Nowak J
J Appl Genet; 2006; 47(3):269-72. PubMed ID: 16877808
[TBL] [Abstract][Full Text] [Related]
12. The c.657del5 variant in the NBN gene predisposes to pancreatic cancer.
Borecka M; Zemankova P; Lhota F; Soukupova J; Kleiblova P; Vocka M; Soucek P; Ticha I; Kleibl Z; Janatova M
Gene; 2016 Aug; 587(2):169-72. PubMed ID: 27150568
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of the NBN gene mutation c.657-661del5 in Southeast Germany.
Maurer MH; Hoffmann K; Sperling K; Varon R
J Appl Genet; 2010; 51(2):211-4. PubMed ID: 20453309
[TBL] [Abstract][Full Text] [Related]
14. 657del5 mutation of the Nijmegen breakage syndrome gene (NBS1) in the Turkish population.
Tekin M; Akcayoz D; Ucar C; Gulen H; Akar N
Hum Biol; 2005 Jun; 77(3):393-7. PubMed ID: 16392640
[TBL] [Abstract][Full Text] [Related]
15. Screening of Nijmegen breakage syndrome 1 mutations in four unrelated families by polymerase chain reaction using sequence-specific primers.
Di Masi A; Antoccia A; Spadoni E; Varon-Mateeva R; Maraschio P; Tanzarella C
Genet Test; 2006; 10(1):24-30. PubMed ID: 16544999
[TBL] [Abstract][Full Text] [Related]
16. Secondary acute monocytic leukemia positive for 11q23 rearrangement in Nijmegen breakage syndrome.
Pastorczak A; Szczepanski T; Trelinska J; Finalet Ferreiro J; Wlodarska I; Mycko K; Polucha A; Sedek L; Meyer C; Marschalek R; Młynarski W
Pediatr Blood Cancer; 2014 Aug; 61(8):1469-71. PubMed ID: 24619942
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of gastrointestinal lymphoma in carriers of the 657del5 NBS1 gene mutation.
Steffen J; Maneva G; Popławska L; Varon R; Mioduszewska O; Sperling K
Int J Cancer; 2006 Dec; 119(12):2970-3. PubMed ID: 16998789
[TBL] [Abstract][Full Text] [Related]
18. Impact of heterozygous c.657-661del, p.I171V and p.R215W mutations in NBN on nibrin functions.
Dzikiewicz-Krawczyk A; Mosor M; Januszkiewicz D; Nowak J
Mutagenesis; 2012 May; 27(3):337-43. PubMed ID: 22131123
[TBL] [Abstract][Full Text] [Related]
19. NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia.
Buslov KG; Iyevleva AG; Chekmariova EV; Suspitsin EN; Togo AV; Kuligina ESh; Sokolenko AP; Matsko DE; Turkevich EA; Lazareva YR; Chagunava OL; Bit-Sava EM; Semiglazov VF; Devilee P; Cornelisse C; Hanson KP; Imyanitov EN
Int J Cancer; 2005 Apr; 114(4):585-9. PubMed ID: 15578693
[TBL] [Abstract][Full Text] [Related]
20. Nijmegen Breakage Syndrome mutations and risk of breast cancer.
Bogdanova N; Feshchenko S; Schürmann P; Waltes R; Wieland B; Hillemanns P; Rogov YI; Dammann O; Bremer M; Karstens JH; Sohn C; Varon R; Dörk T
Int J Cancer; 2008 Feb; 122(4):802-6. PubMed ID: 17957789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
